BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 83919)

  • 1. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition.
    Thomson DM; Tataryn DN; Lopez M; Schwartz R; MacFarlane JK
    Cancer Res; 1979 Feb; 39(2 Pt 2):638-43. PubMed ID: 83918
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
    Goldrosen MH; Howell JH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 13. Tube LAI assay in diagnosis and monitoring of a cancer disease.
    Hasek M; Holán V; Kousalová M
    Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):587-92. PubMed ID: 367585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemocytometer leukocyte adherence inhibition technique.
    Maluish AE; Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leukocyte adherence inhibition test in tumor patients].
    Martínez Martínez B; Ordóñez Gallego A; Juárez Alonso S; González Barón M; Montero García JM
    Rev Esp Oncol; 1982; 29(4):735-42. PubMed ID: 6927371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic diagnosis of malignant neoplasms. I].
    Shuster J; Thomson DM; Fuks A; Gold P
    Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.